Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Dilated Cardiomyopathy Therapeutics
The 2025-2030 World Outlook for Dilated Cardiomyopathy Therapeutics This study covers the world outlook for dilated cardiomyopathy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Pneumonia Therapeutic Drugs
The 2025-2030 World Outlook for Pneumonia Therapeutic Drugs This study covers the world outlook for pneumonia therapeutic drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in ... Read More
-
The 2025-2030 World Outlook for Sexually Transmitted Diseases (STDs) Drugs
The 2025-2030 World Outlook for Sexually Transmitted Diseases (STDs) Drugs This study covers the world outlook for sexually transmitted diseases (STDs) drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments
The 2025-2030 World Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments This study covers the world outlook for non-Hodgkin's lymphoma and chronic lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Fragment-Based Drug Discovery
The 2025-2030 World Outlook for Fragment-Based Drug Discovery This study covers the world outlook for fragment-based drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics This study covers the world outlook for non-Hodgkin lymphoma chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I ... Read More
-
The 2025-2030 World Outlook for Disease Care Management Solutions
The 2025-2030 World Outlook for Disease Care Management Solutions This study covers the world outlook for disease care management solutions across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in q ... Read More
-
The 2025-2030 World Outlook for Lymphoma Therapeutics
The 2025-2030 World Outlook for Lymphoma Therapeutics This study covers the world outlook for lymphoma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Sexual Dysfunction Drugs
The 2025-2030 World Outlook for Sexual Dysfunction Drugs This study covers the world outlook for sexual dysfunction drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Drug Discovery and Development RNA Interference (RNAi)
The 2025-2030 World Outlook for Drug Discovery and Development RNA Interference (RNAi) This study covers the world outlook for drug discovery and development RNA interference (RNAi) across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential indust ... Read More
-
The 2025-2030 World Outlook for Immunology
The 2025-2030 World Outlook for Immunology This study covers the world outlook for immunology across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for Therapeutics for Narcolepsy with Cataplexy
The 2025-2030 World Outlook for Therapeutics for Narcolepsy with Cataplexy This study covers the world outlook for therapeutics for narcolepsy with cataplexy across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), fo ... Read More
-
The 2025-2030 World Outlook for Post-Exposure Prophylaxis Rabies Treatments
The 2025-2030 World Outlook for Post-Exposure Prophylaxis Rabies Treatments This study covers the world outlook for post-exposure prophylaxis rabies treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics
The 2025-2030 World Outlook for Colorectal Cancer Chemotherapy Therapeutics This study covers the world outlook for colorectal cancer chemotherapy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), ... Read More
-
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies
The 2025-2030 World Outlook for Alpha-1 Antitrypsin Deficiency Treatment Augmentation Therapies This study covers the world outlook for alpha-1 antitrypsin deficiency treatment augmentation therapies across more than 190 countries. For each year reported, estimates are given for the latent demand, o ... Read More
-
The 2025-2030 World Outlook for Lysosomal Disease Treatments
The 2025-2030 World Outlook for Lysosomal Disease Treatments This study covers the world outlook for lysosomal disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for Lysosomal Storage Diseases Treatments
The 2025-2030 World Outlook for Lysosomal Storage Diseases Treatments This study covers the world outlook for lysosomal storage diseases treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the coun ... Read More
-
The 2025-2030 World Outlook for Systemic Psoriasis Therapeutics
The 2025-2030 World Outlook for Systemic Psoriasis Therapeutics This study covers the world outlook for systemic psoriasis therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Biosimulation Technologies
The 2025-2030 World Outlook for Biosimulation Technologies This study covers the world outlook for biosimulation technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Lipopeptide MRSA Drugs
The 2025-2030 World Outlook for Lipopeptide MRSA Drugs This study covers the world outlook for lipopeptide MRSA drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Substance Abuse Treatments
The 2025-2030 World Outlook for Substance Abuse Treatments This study covers the world outlook for substance abuse treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Lung Cancer Therapeutics
The 2025-2030 World Outlook for Lung Cancer Therapeutics This study covers the world outlook for lung cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Liver Disease Treatments
The 2025-2030 World Outlook for Liver Disease Treatments This study covers the world outlook for liver disease treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Opportunity Assessment of RNA-Based Therapeutics and Vaccines
The 2025-2030 World Outlook for Opportunity Assessment of RNA-Based Therapeutics and Vaccines This study covers the world outlook for opportunity assessment of RNA-based therapeutics and vaccines across more than 190 countries. For each year reported, estimates are given for the latent demand, or po ... Read More
-
The 2025-2030 World Outlook for Bone Metabolism Therapeutics
The 2025-2030 World Outlook for Bone Metabolism Therapeutics This study covers the world outlook for bone metabolism therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
Research Assistance
